 Mallinckrodt PLC said its fullyear results are looking promising as the company posted a narrower fiscal thirdquarter loss amid a surge in specialty pharmaceutical revenue  The company boosted its fullyear adjusted earnings guidance by  cents to  to  while raising its revenue outlook to  billion to  billion from the previous range of  billion to  billion  This
  